ArticleWomen's health (London, England)
Cardiac function in women receiving dual anti-Her2 antibodies (trastuzumab and pertuzumab) combined with chemotherapy for breast cancer.
Jamal Zekri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
cites it